PFE (Pfizer) How high will it go? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go?

PFE 25.75

-0.1%

3:38 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Barron Von Hymen who wrote (944)	4/3/1998 11:06:00 AM
From: WillDearborn	Read Replies (1) of 9523

You missed one major product in development. Topiglan, in development by Macrochem (MCHM). Currently near completion of PhaseIIB trials, the efficacy shows a 75% success rate with NO side effects. The patients in the MCHM trial are all with "physical" reasons for erectile dysfunction, unlike Viagra which included those with "pyscho" reasons. Viagra also excluded patients with certain heart ailments on other drugs, because after all, Vaigra originally was intended as a heart drug. With Viagra side effects of headaches, nausea, diarrhea and visual disturbances, Viagra will not satisfy all of the potential consumers. There is room for more than one player in this market. wd

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next